Hsieh J K, Chan F S, O'Connor D J, Mittnacht S, Zhong S, Lu X
Ludwig Institute for Cancer Research, Imperial College School of Medicine, London, United Kingdom.
Mol Cell. 1999 Feb;3(2):181-93. doi: 10.1016/s1097-2765(00)80309-3.
The binding of RB to MDM2 is shown to be essential for RB to overcome both the antiapoptotic function of MDM2 and the MDM2-dependent degradation of p53. The RB-MDM2 interaction does not prevent MDM2 from inhibiting p53-dependent transcription, but the RB-MDM2 complex still binds to p53. Since RB specifically rescues the apoptotic function but not the transcriptional activity of p53 from negative regulation by MDM2, transactivation by wild-type p53 is not required for the apoptotic function of p53. However, an RB-MDM2-p53 trimeric complex is active in p53-mediated transrepression. These data link directly the function of two tumor suppressor proteins and demonstrate a novel role of RB in regulating the apoptotic function of p53.
RB与MDM2的结合对于RB克服MDM2的抗凋亡功能以及MDM2依赖的p53降解至关重要。RB-MDM2相互作用并不阻止MDM2抑制p53依赖的转录,但RB-MDM2复合物仍与p53结合。由于RB特异性地挽救了p53被MDM2负调控的凋亡功能而非转录活性,因此p53的凋亡功能并不需要野生型p53的反式激活。然而,RB-MDM2-p53三聚体复合物在p53介导的反式抑制中具有活性。这些数据直接将两种肿瘤抑制蛋白的功能联系起来,并证明了RB在调节p53凋亡功能中的新作用。